Results 151 to 160 of about 15,000 (182)
Some of the next articles are maybe not open access.

Recombinant human erythropoietin.

Nederlands tijdschrift voor geneeskunde, 1988
BECK ANTON K   +3 more
openaire   +3 more sources

The promise of recombinant human erythropoietin.

Seminars in hematology, 1989
Clinical trials have clearly demonstrated the efficacy of recombinant human erythropoietin (r-HuEPO) (EPOGEN [epoetin alfa]; AMGEN Inc, Thousand Oaks, CA) in the treatment of the anemia associated with end-stage renal disease (ESRD). Nearly all dialysis patients treated with r-HuEPO have responded by reaching target hematocrit levels within 8 to 12 ...
openaire   +1 more source

Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin

New England Journal of Medicine, 1987
Joseph W Eschbach, J C Egrie, J K Browne
exaly  

Recombinant Human Erythropoietin in Children With Cancer

Journal of Pediatric Hematology/Oncology, 1998
M L, MacMillan, M H, Freedman
openaire   +2 more sources

Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity?

European Journal of Pediatrics, 2000
Francesca Gallini   +2 more
exaly  

Treatment with Recombinant Human Erythropoietin in Children with Malignancies

Pediatric Hematology and Oncology, 1996
E Stiakaki, E Lydaki, M Kalmanti
exaly  

Home - About - Disclaimer - Privacy